Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:31 pm Purchase | 2024-09-30 | 13G | Ironwood Pharmaceuticals, Inc. IRWD | Armistice Capital, LLC | 8,200,000 5.130% | 8,200,000 (New Position) | Filing History |
| 2024-11-14 3:31 pm Purchase | 2024-09-30 | 13G | Inhibikase Therapeutics, Inc. IKT | Armistice Capital, LLC | 758,885 9.990% | 758,885 (New Position) | Filing History |
| 2024-11-14 3:30 pm Purchase | 2024-09-30 | 13G | Gaxos.ai Inc. GXAI | Armistice Capital, LLC | 207,632 9.990% | 207,632 (New Position) | Filing History |
| 2024-11-14 3:30 pm Purchase | 2024-09-30 | 13G | 5E Advanced Materials Inc. FEAM | Armistice Capital, LLC | 216,522 7.230% | 216,522 (New Position) | Filing History |
| 2024-11-14 3:29 pm Purchase | 2024-09-30 | 13G | Evaxion Biotech A/S EVAX | Armistice Capital, LLC | 111,055 9.990% | 111,055 (New Position) | Filing History |
| 2024-11-14 3:29 pm Purchase | 2024-09-30 | 13G | Enlivex Therapeutics Ltd. ENLV | Armistice Capital, LLC | 2,175,884 9.990% | 2,175,884 (New Position) | Filing History |
| 2024-11-14 3:29 pm Purchase | 2024-09-30 | 13G | Ekso Bionics Holdings, Inc. EKSO | Armistice Capital, LLC | 9,745 9.990% | 7,973 (+449.98%) | Filing History |
| 2024-11-14 3:28 pm Purchase | 2024-09-30 | 13G | Edible Garden AG Incorporated EDBL | Armistice Capital, LLC | 82,091 9.990% | 82,091 (New Position) | Filing History |
| 2024-11-14 3:28 pm Purchase | 2024-09-30 | 13G | Danimer Scientific, Inc. DNMR | Armistice Capital, LLC | 12,018,677 9.900% | 12,018,677 (New Position) | Filing History |
| 2024-11-14 3:27 pm Purchase | 2024-09-30 | 13G | ALTAMIRA THERAPEUTICS LTD SHS CYTOF | Armistice Capital, LLC | 408,110 9.990% | 408,110 (New Position) | Filing History |
| 2024-11-14 3:27 pm Purchase | 2024-09-30 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Armistice Capital, LLC | 928 9.990% | 928 (New Position) | Filing History |
| 2024-11-14 3:26 pm Purchase | 2024-09-30 | 13G | Clene Inc. CLNN | Armistice Capital, LLC | 700,000 8.770% | 700,000 (New Position) | Filing History |
| 2024-11-14 3:25 pm Purchase | 2024-09-30 | 13G | Banzai International, Inc. BNZI | Armistice Capital, LLC | 16,103 9.990% | 16,103 (New Position) | Filing History |
| 2024-11-14 3:25 pm Purchase | 2024-09-30 | 13G | Bionomics Limited BNOX | Armistice Capital, LLC | 145,462 9.990% | 145,462 (New Position) | Filing History |
| 2024-11-14 3:24 pm Purchase | 2024-09-30 | 13G | Brainstorm Cell Therapeutics Inc. BCLI | Armistice Capital, LLC | 8,083,946 9.990% | 8,083,946 (New Position) | Filing History |
| 2024-11-14 3:24 pm Purchase | 2024-09-30 | 13G | ACCELERATE DIAGNOSTICS INC AXDXQ | Armistice Capital, LLC | 2,400,000 9.930% | 2,400,000 (New Position) | Filing History |
| 2024-11-14 3:23 pm Purchase | 2024-09-30 | 13G | ASPIRA WOMENS HEALTH INC N AWHL | Armistice Capital, LLC | 1,256,000 7.760% | 1,256,000 (New Position) | Filing History |
| 2024-11-14 3:23 pm Purchase | 2024-09-30 | 13G | Avinger, Inc. AVGR | Armistice Capital, LLC | 304,011 9.990% | 236,785 (+352.22%) | Filing History |
| 2024-11-14 3:22 pm Purchase | 2024-09-30 | 13G | Avenue Therapeutics, Inc. ATXI | Armistice Capital, LLC | 115,000 7.210% | 115,000 (New Position) | Filing History |
| 2024-11-14 3:22 pm Purchase | 2024-09-30 | 13G | Assembly Biosciences, Inc. ASMB | Armistice Capital, LLC | 354,000 5.580% | 354,000 (New Position) | Filing History |